Loss of Bright/ARID3a function promotes developmental plasticity.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 20680960.
- Also identified by DOI 10.1002/stem.491 and PMC identifier 2977942.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
B-cell regulator of immunoglobulin heavy chain transcription (Bright)/ARID3a, an A+T-rich interaction domain protein, was originally discovered in B lymphocyte lineage cells. However, expression patterns and high lethality levels in knockout mice suggested that it had additional functions. Three independent lines of evidence show that functional inhibition of Bright results in increased developmental plasticity. Bright-deficient cells from two mouse models expressed a number of pluripotency-associated gene products, expanded indefinitely, and spontaneously differentiated into cells of multiple lineages. Furthermore, direct knockdown of human Bright resulted in colonies capable of expressing multiple lineage markers. These data suggest that repression of this single molecule confers adult somatic cells with new developmental options.
Medical subject headings
- Cell Differentiation
- Cell Lineage
- Cell Proliferation
- DNA-Binding Proteins
- Pluripotent Stem Cells
- Transcription Factors